BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 23091461)

  • 1. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.
    Zimmermann HW; Trautwein C; Tacke F
    Front Physiol; 2012; 3():56. PubMed ID: 23091461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo.
    Tacke F
    Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S27. PubMed ID: 23259611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes and macrophages as cellular targets in liver fibrosis.
    Heymann F; Trautwein C; Tacke F
    Inflamm Allergy Drug Targets; 2009 Sep; 8(4):307-18. PubMed ID: 19534673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
    Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
    Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
    Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
    Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury.
    Mossanen JC; Krenkel O; Ergen C; Govaere O; Liepelt A; Puengel T; Heymann F; Kalthoff S; Lefebvre E; Eulberg D; Luedde T; Marx G; Strassburg CP; Roskams T; Trautwein C; Tacke F
    Hepatology; 2016 Nov; 64(5):1667-1682. PubMed ID: 27302828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
    Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
    PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
    Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage heterogeneity in liver injury and fibrosis.
    Tacke F; Zimmermann HW
    J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.
    Aoyama T; Inokuchi S; Brenner DA; Seki E
    Hepatology; 2010 Oct; 52(4):1390-400. PubMed ID: 20683935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse.
    Dambach DM; Watson LM; Gray KR; Durham SK; Laskin DL
    Hepatology; 2002 May; 35(5):1093-103. PubMed ID: 11981759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
    Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
    Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans.
    Antoniades CG; Quaglia A; Taams LS; Mitry RR; Hussain M; Abeles R; Possamai LA; Bruce M; McPhail M; Starling C; Wagner B; Barnardo A; Pomplun S; Auzinger G; Bernal W; Heaton N; Vergani D; Thursz MR; Wendon J
    Hepatology; 2012 Aug; 56(2):735-46. PubMed ID: 22334567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
    Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
    Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.